FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement

Key Dates

Due Date

Posted Date

Agency & Value

Agency

DEFENSE THREAT REDUCTION AGENCY

Contract Value

Not provided

Codes & Classification

Solicitation Number

HDTRA122S0002

NAICS

—

Classification Code

AC32

Additional Details

Set Aside

None

Place of Performance

—

SourceSAM

The Defense Threat Reduction Agency (DTRA) has issued the FY2022-2026 Chemical / Biological Technologies Broad Agency Announcement (BAA), procurement identifier HDTRA122S0002, as a solicitation for innovative research and development projects. This BAA serves as a five-year, open, continuous vehicle for the release of specific research topics, enabling the agency to address evolving needs in chemical and biological defense technologies. The BAA will remain open for a total of 60 months from its initial release, with individual topic calls announced periodically throughout its lifecycle. The primary purpose of this procurement is to advance the state-of-the-art capabilities that enable U.S. military forces to operate effectively in chemical and biological warfare environments. DTRA’s Research and Development for Chemical and Biological (RD-CB) mission, under the Department of Defense (DoD), seeks to identify, develop, and transition science and technology solutions that can be integrated into joint acquisition programs. The agency’s priorities are shaped by ongoing assessments of military and civilian chemical and biological defense science, operational requirements, threat analyses, and national defense strategies. The scope of the BAA is focused on projects that fall within Technology Readiness Levels (TRL) 3-6, as defined in Attachment 1 of the solicitation. Proposed solutions should aim to achieve a TRL between 4 and 6 upon completion of development efforts. For technologies at TRL 4 or higher, proposers are also expected to consider Manufacturing Readiness Level (MRL) requirements, ensuring that solutions are not only technically viable but also manufacturable at scale. DTRA encourages both intramural and extramural research participation, recognizing the importance of collaboration between government, academia, and industry in fulfilling the objectives of the Chemical and Biological Defense Program (CBDP). The agency is seeking optimum approaches to meet its technology objectives, with a particular emphasis on projects that demonstrate potential for transition to acquisition and operational use. Key requirements and expected deliverables for this BAA include: - Submission of proposals that address specific topic calls released during the BAA’s open period. - Alignment of proposed technologies with the TRL and MRL criteria outlined in the solicitation. - Responsiveness to deadlines for questions and proposal submissions associated with each topic call (e.g., recent deadlines for Topic Calls 4, 5, and 6). - Adherence to revised sections and attachments as updated throughout the BAA’s lifecycle. The contracting entity for this opportunity is the Defense Threat Reduction Agency, a federal office dedicated to countering threats posed by weapons of mass destruction. The Product Service Code associated with this BAA is AC32, which pertains to research and development in defense-related chemical and biological technologies. Interested parties should direct inquiries and proposal submissions to the DTRA RD-CB BAA Mailbox at [email protected]. The solicitation and all associated updates, attachments, and topic calls can be accessed via the official SAM.gov opportunity page: https://sam.gov/opp/52e119b3ee594efc9565d5baac30fcbb/view. This BAA is a solicitation for research and development and is not a set-aside for any specific socioeconomic category. Contractors should review the BAA and its attachments for detailed instructions, eligibility criteria, and evaluation factors. The opportunity remains active, with multiple topic calls and associated deadlines for questions and proposal submissions occurring throughout the five-year period. For contractors with expertise in chemical and biological defense technologies, particularly those capable of advancing solutions from early-stage research through to higher readiness and manufacturability, this BAA represents a significant opportunity to contribute to national defense priorities and to collaborate with DTRA in shaping the future of chemical and biological threat reduction.

Documents25